×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
New Trial Design Approaches: Including New Endpoints
Session Chair(s)
John Reites
Chief Executive Officer
THREAD, United States
Can better endpoint structures be developed that capture disease status and medical product performance, yet still allow interpretability? Can we employ trial designs that are not ‘one size fits all’ and generate better data more efficiently?
Learning Objective : Discuss how the clinical trial enterprise may be enhanced with novel designs.
Speaker(s)
Happy 2nd Birthday ResearchKit: New Opportunities and Limitations Using ResearchKit in Your Mobile Health Studies
John Reites
THREAD, United States
Chief Executive Officer
Digital Biomarkers From Real World Mobile Sensor Data in Clinical Trials: How Relevant are They?
Christian Gossens, PhD
F. Hoffmann-La Roche Ltd., Switzerland
Global Area Head, Digital Biomarker Informatics
Generating Novel Endpoints Through Mobile Technology: A Promising and Realistic New Approach to Trial Design
Robert DiCicco, PharmD
TransCelerate Biopharma Inc., United States
Vice President, Portfolio Management
Have an account?